Track Corcept Therapeutics's current assets ($440M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Corcept Therapeutics (CORT) currently reports a current assets of $440M as of June 2026. That compares with $440M in the prior-year period — down 0.8% year over year. Use the charts on this page to explore Corcept Therapeutics's current assets history and peer comparisons.
Corcept Therapeutics's current assets decreased from $440M to $440M — a 0.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Corcept Therapeutics reported $440M in current assets as of June 2026. That compares with $440M in the prior-year period — down 0.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $440M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Corcept Therapeutics, and consider following CORT for alerts when major investors trade the stock.
Corcept Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $440M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CORT with unrelated industries.